In Reply to Gultekin et al

To the Editor: The management options for recurrent pediatric central nervous system (CNS) malignancies include systemic therapy, surgical resection, radiation therapy, or a combination thereof. We reported our multi-institutional experience of the clinical outcomes of 67 pediatric patients treated who underwent reirradiation in the CNS (1, 2). Median overall survival from the end of reirradiation was 12.8 months in the entire cohort and 20.5 months and 8.4 months for patients with recurrent ependymoma and medulloblastoma, respectively.

https://ift.tt/2GI9fST